Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke.
about
Evaluation of Gene Therapy as an Intervention Strategy to Treat Brain Injury from StrokeIschemia, Immunosuppression and Infection--Tackling the Predicaments of Post-Stroke ComplicationsUpdate on Inflammatory Biomarkers and Treatments in Ischemic StrokeMechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke[(18)F]DPA-714 PET imaging of AMD3100 treatment in a mouse model of stroke.Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.In vivo albumin labeling and lymphatic imaging.Reduction of rat brain CD8+ T-cells by levodopa/benserazide treatment after experimental stroke.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imagingDynamics of major histocompatibility complex class II-positive cells in the postischemic brain--influence of levodopa treatment.Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental strokeMicroarray Profiling and Co-Expression Network Analysis of LncRNAs and mRNAs in Neonatal Rats Following Hypoxic-ischemic Brain DamageCXCL12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury in Mouse Brain.CX3C chemokine receptor 1 deficiency modulates microglia morphology but does not affect lesion size and short-term deficits after experimental stroke.Extracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery.Splenic responses in ischemic stroke: new insights into stroke pathology.The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects.Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases.Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain.Preconditioning-induced CXCL12 upregulation minimizes leukocyte infiltration after stroke in ischemia-tolerant mice.Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.SDF1-CXCR4 Signaling Maintains Central Post-Stroke Pain through Mediation of Glial-Neuronal InteractionsAnti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.Nanobodies as modulators of inflammation: potential applications for acute brain injury.Brain-immune interactions in perinatal hypoxic-ischemic brain injury.Inhibiting the Migration of M1 Microglia at Hyperacute Period Could Improve Outcome of tMCAO Rats.CXCR4 antagonist AMD3100 reverses the neurogenesis and behavioral recovery promoted by forced limb-use in stroke rats.CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction.MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo.Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.The role of dopaminergic immune cell signalling in poststroke inflammation.
P2860
Q26744103-E8CB09D1-811B-4DD8-B4EB-796FF3E8758EQ26770298-769F7799-F07F-4178-92F0-36E182B52466Q28078744-5F827028-F810-4DBB-8906-3E748B540883Q28083718-DF192BF9-3F6A-4FA5-93FC-B7F7088F1F15Q34293578-1B880FAE-01B1-41AD-A7AF-7F09A3283CADQ34718326-6B615ADF-F9EF-42D0-A9C9-6FA97F07DF68Q34926262-14C43A76-FA20-4377-A8D1-A7D19EFD5586Q35154574-7B103AB7-F9D8-42EC-94DE-FCEF661AFCBAQ35227508-F7A6EBC7-3496-4F9C-A0CC-3945BCA9F76EQ35236218-E2650F1A-43F4-4E6B-8EF9-608570A7CD7DQ35604382-3B47A3A5-4772-4DA3-88E7-45CF540F6F4DQ36039728-A54DB23E-4B58-4006-A1FC-E4E310C31372Q36067861-DF0F700D-F049-4F2D-96EA-F0FD3B2A8E15Q36243228-73B2C794-F6BE-4F90-8302-37956972DCC9Q36307057-FD50DFC5-00F9-4137-A81D-2489ACCE37D4Q38283268-D35F9076-23BF-476B-A020-C91596ECEB19Q38562255-2CC7C052-0E7E-4A73-B5AB-4C7399727BF4Q38827531-72486A19-F98E-4B22-A9E5-DB9EB4C352CFQ38903653-FAFFF5BE-8AE1-4F71-B020-B254793C4742Q39113859-7E976D55-F5BC-4EF8-B710-78ACEF6FEC07Q39896010-F61674DC-30AF-426D-A045-93AA118363A7Q40109819-EA68D010-2427-4D89-B0EC-B369F5220121Q41074630-E244D76F-EEA4-4A33-AB78-68AC8FAA2C8AQ41314097-09EAB649-94D6-4F38-9075-97CDB347C00EQ42105969-6605E6E4-6486-4A1C-84A1-3CDC2E61C554Q47624437-53834606-9106-4594-95C6-E80FF06B371AQ48017037-A1498947-A778-48C6-95FF-FCAAADAB367DQ50556812-99928D9C-148E-4C46-9717-3BD1DC59FBB9Q51724009-C994DAC7-F915-496E-9648-963B20F8E4ADQ52679501-8F4E9899-E919-43AF-8983-A41A6AC55DBEQ53208361-232C0633-0BCD-42E0-BFFC-14900C96E3D2Q55035979-FE39EFE6-A827-4A74-8712-B1BD2130F81D
P2860
Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@en
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@nl
type
label
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@en
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@nl
prefLabel
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@en
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@nl
P2093
P2860
P356
P1476
Inhibition of CXCL12 signaling ...... ctional recovery after stroke.
@en
P2093
Enida Kuric
Helene L Walter
Karsten Ruscher
Shohreh Issazadeh-Navikas
P2860
P304
P356
10.1038/JCBFM.2013.71
P577
2013-05-01T00:00:00Z